Author |
Title |
JournalName |
Year D |
Click on Column Headers to Re-Sort The Current List |
Fuller RW, Hines CW, Mill... |
Lowering of Brain Serotonin Levels by Chloramphetamines |
Biochem Pharmacol |
1965 |
Barfknecht CF, Nichols DE |
Potential psychotomimetics, Bromomethoxyamphetamines |
J Med Chem |
1971 |
Barfknecht CF, Nichols DE |
Potential psychotomimetics. Bromomethoxyamphetamines |
J Med Chem |
1971 |
Sreenivasan VR |
Problems in Identification of Methylenediony and Methoxy Amphetamines |
Journal of Criminal ... |
1972 |
Barfknecht CF, Nichols DE... |
Potential Psychotomimetics. 2-Amino-1,2,3,4-tetrahydronaphthalene Anal... |
J Med Chem |
1973 |
Nichols DE |
Potential Psychotomimetics Bromomethoxyamphetamines And Structural Con... |
Diss.Abstr.Intern. B |
1973 |
Cooper PD |
Beta-chloroethylamines related to mescaline |
J Med Chem |
1973 |
Herman ZS |
5-Hydroxytptamine Metabolism in the Brain Under the Influence of Psych... |
Pol.J.Pharmacol.Phar... |
1975 |
Smith SJ |
Effects Of Psychotropic Drugs On Brain Nuclear RNA |
Psychopharmacology B... |
1975 |
Arushanyan EB |
The Mesolimbic System of the Brain and its Participation in the Action... |
Farmakol. i Toksikol... |
1977 |
Berde B |
Pharmacology of Ergot Alkaloids in Clinical Use |
Med.J.Australia |
1978 |
Persson SÅ, Johansson H |
The Effect Of Lysergic Acid Diethylam1de (LSD) and 2-bromo-lysergic Ac... |
Brain Research |
1978 |
White FJ, Appel JB |
A Neuropharmacological Analysis of the Discriminative Stimulus Propert... |
Psychopharmacology |
1981 |
Schmidt CJ, Sonsalla PK, ... |
Methamphetamine-induced depression of monoamine synthesis in the rat: ... |
J Neurochem |
1985 |
Noggle FT Jr, DeRuiter J,... |
Synthesis, identification, and acute toxicity of some N-alkyl derivati... |
J Assoc Off Anal Che... |
1987 |
Stone DM, Merchant KM, Ha... |
Immediate and long-term effects of 3,4-methylenedioxymethamphetamine o... |
Neuropharmacology |
1987 |
Buchanan JF, Brown CR |
'Designer drugs'. A problem in clinical toxicology |
Med Toxicol Adverse ... |
1988 |
Scallet AC, Lipe GW, Ali ... |
Neuropathological evaluation by combined immunohistochemistry and dege... |
Neurotoxicology |
1988 |
Schmidt CJ, Taylor VL |
Direct central effects of acute methylenedioxymethamphetamine on serot... |
Eur J Pharmacol |
1988 |
Stanford MW |
Designer drugs: Medical aspects and clinical management |
Alcoholism Treatment... |
1988 |
Fitzgerald RL, Blanke RV,... |
Determination of 3,4-methylenedioxyamphetamine and 3,4-methylenedioxym... |
J Chromatogr |
1989 |
Johnson M, Stone DM, Bush... |
Glucocorticoids and 3,4-methylenedioxymethamphetamine (MDMA)-induced n... |
Eur J Pharmacol |
1989 |
Schmidt CJ |
Acute and long-term neurochemical effects of methylenedioxymethampheta... |
NIDA Res Monogr |
1989 |
Stone DM, Hanson GR, Gibb... |
In vitro reactivation of rat cortical tryptophan hydroxylase following... |
J Neurochem |
1989 |
Gibb JW, Stone DM, Johnso... |
Role of dopamine in the neurotoxicity induced by amphetamines and rela... |
NIDA Res Monogr |
1989 |
Callaway CW, Wing LL, Gey... |
Serotonin release contributes to the locomotor stimulant effects of 3,... |
J Pharmacol Exp Ther |
1990 |
Nash JF, Meltzer HY, Gude... |
Effect of 3,4-methylenedioxymethamphetamine on 3,4-dihydroxyphenylalan... |
J Neurochem |
1990 |
Schmidt CJ, Abbate GM, Bl... |
Selective 5-hydroxytryptamine2 receptor antagonists protect against th... |
J Pharmacol Exp Ther |
1990 |
Schmidt CJ, Black CK, Tay... |
Antagonism of the neurotoxicity due to a single administration of meth... |
Eur J Pharmacol |
1990 |
Schmidt CJ, Kehne JH |
Neurotoxicity of MDMA: neurochemical effects |
Ann N Y Acad Sci |
1990 |
Johnson MP, Frescas SP, O... |
Synthesis and pharmacological examination of 1-(3-methoxy-4-methylphen... |
J Med Chem |
1991 |
Johnson MP, Frescas SP, O... |
Synthesis and pharmacological examination of 1-(3-methoxy-4-methylphen... |
J Med Chem |
1991 |
Pan HS, Wang RY |
The action of (+/-)-MDMA on medial prefrontal cortical neurons is medi... |
Brain Res |
1991 |
Schechter MD |
Effect of serotonin depletion by p-chlorophenylalanine upon discrimina... |
Gen Pharmacol |
1991 |
Schmidt CJ, Taylor VL, Ab... |
5-HT2 antagonists stereoselectively prevent the neurotoxicity of 3,4-m... |
J Pharmacol Exp Ther |
1991 |
Schmidt CJ, Black CK, Tay... |
The 5-HT2 receptor antagonist, MDL 28,133A, disrupts the serotonergic-... |
Eur J Pharmacol |
1992 |
Schmidt CJ, Fadayel GM, S... |
5-HT2 receptors exert a state-dependent regulation of dopaminergic fun... |
Eur J Pharmacol |
1992 |
Zhao ZY, Castagnoli N Jr,... |
Synthesis and neurotoxicological evaluation of putative metabolites of... |
Chem Res Toxicol |
1992 |
Bohn M, Bohn G, Blaschke ... |
Synthesis markers in illegally manufactured 3,4-methylenedioxyamphetam... |
Int J Legal Med |
1993 |
Huang X, Nichols DE |
5-HT2 receptor-mediated potentiation of dopamine synthesis and central... |
Eur J Pharmacol |
1993 |
Renton RJ, Cowie JS, Oon ... |
A study of the precursors, intermediates and reaction by-products in t... |
Forensic Sci Int |
1993 |
Shiue CY, Shiue GG, Rysav... |
Fluorine-18 and carbon-11 labeled amphetamine analogs--synthesis, dist... |
Nucl Med Biol |
1993 |
Monte AP, Marona-Lewicka ... |
Synthesis and pharmacological examination of benzofuran, indan, and te... |
J Med Chem |
1993 |
Marona-Lewicka D, Nichols... |
Behavioral effects of the highly selective serotonin releasing agent 5... |
Eur J Pharmacol |
1994 |
Schmidt CJ, Sullivan CK, ... |
Blockade of striatal 5-hydroxytryptamine2 receptors reduces the increa... |
J Neurochem |
1994 |
White SR, Duffy P, Kaliva... |
Methylenedioxymethamphetamine depresses glutamate-evoked neuronal firi... |
Neuroscience |
1994 |
Green AR, Cross AJ, Goodw... |
Review of the pharmacology and clinical pharmacology of 3,4-methylened... |
Psychopharmacology (... |
1995 |
Miller RT, Lau SS, Monks ... |
Effects of intracerebroventricular administration of 5-(glutathion-S-y... |
Chem Res Toxicol |
1996 |
Gudelsky GA, Nash JF |
Carrier-mediated release of serotonin by 3,4-methylenedioxymethampheta... |
J Neurochem |
1996 |
Obradovic T, Imel KM, Whi... |
Methylenedioxymethamphetamine-induced inhibition of neuronal firing in... |
Neuroscience |
1996 |
Gifford AN, Minabe Y, Too... |
Examination of the action of 3,4-methylenedioxymethamphetamine on rat ... |
Synapse |
1996 |
Geyer MA |
Serotonergic functions in arousal and motor activity |
Behav Brain Res |
1996 |
McKenna DJ |
Plant hallucinogens: springboards for psychotherapeutic drug discovery |
Behav Brain Res |
1996 |
Obradovic T, Imel KM, Whi... |
Methylenedioxymethamphetamine-induced inhibition of neuronal firing in... |
Neuroscience |
1996 |
Ensslin HK, Maurer HH, Go... |
Metabolism of racemic 3,4-methylenedioxyethylamphetamine in humans. Is... |
Drug Metab Dispos |
1997 |
Dal Cason TA |
The characterization of some 3,4-methylenedioxycathinone MDCATH homolo... |
Forensic Science Int... |
1997 |
Muck-Seler D, Takahashi S... |
The effect of MDMA (3,4-methylenedioxymethamphetamine) on the 5-HT syn... |
Brain Res |
1998 |
Klee H |
The love of speed: An analysis of the enduring attraction of amphetami... |
Journal of Drug Issu... |
1998 |
Sprague JE, Everman SL, N... |
An integrated hypothesis for the serotonergic axonal loss induced by 3... |
Neurotoxicology |
1998 |
Sabol KE, Seiden LS |
Reserpine attenuates D-amphetamine and MDMA-induced transmitter releas... |
Brain Res |
1998 |
Parker MA, Marona-Lewicka... |
Synthesis and pharmacological evaluation of ring-methylated derivative... |
J Med Chem |
1998 |
Westwood SC, Hanson GR |
Effects of stimulants of abuse on extrapyramidal and limbic neuropepti... |
J Pharmacol Exp Ther |
1999 |
Nishisawa S, Mzengeza S, ... |
Acute effects of 3,4-methylenedioxymethamphetamine on brain serotonin ... |
Neurochem Int |
1999 |
Schirren CA, Berghaus TM,... |
Thrombotic thrombocytopenic purpura after Ecstasy-induced acute liver ... |
Ann Intern Med |
1999 |
Erdtmann-Vourliotis M, Ma... |
Acute injection of drugs with low addictive potential (delta(9)-tetrah... |
Brain Res Mol Brain ... |
1999 |
Aalberg L, DeRuiter J, No... |
Chromatographic and Mass Spectral Methods of Identification for the Si... |
J Chromatogr Sci |
2000 |
Christophersen AS |
Amphetamine designer drugs - an overview and epidemiology |
Toxicol Lett |
2000 |
Kuhn DM, Geddes TJ |
Molecular footprints of neurotoxic amphetamine action [In Process Cita... |
Ann N Y Acad Sci |
2000 |
Chambers JJ, Kurrasch-Orb... |
Enantiospecific synthesis and pharmacological evaluation of a series o... |
J Med Chem |
2001 |
Frank DA, Augustyn M, Kni... |
Growth, development, and behavior in early childhood following prenata... |
JAMA |
2001 |
O'Shea E, Easton N, Fry J... |
Protection against 3,4-methylenedioxymethamphetamine-induced neurodege... |
J Neurochem |
2002 |
Boot BP, Mechan AO, McCan... |
MDMA- and p-chlorophenylalanine-induced reduction in 5-HT concentratio... |
Eur J Pharmacol |
2002 |
Lebsanft HB, Mayerhofer A... |
Is the Ecstasy-induced ipsilateral rotation in 6-hydroxydopamine unila... |
J Neural Transm |
2003 |
Easton N, Fry J, O'Shea E... |
Synthesis, in vitro formation, and behavioural effects of glutathione ... |
Brain Res |
2003 |
Dafters RI, Biello SM |
The effect of 3,4-methylenedioxymethamphetamine ('Ecstasy') on seroton... |
Neurosci Lett |
2003 |
Moyano S, Frechilla D, De... |
NMDA receptor subunit and CaMKII changes in rat hippocampus induced by... |
Psychopharmacology (... |
2004 |
Garcia-Osta A, Del Rio J,... |
Increased CRE-binding activity and tryptophan hydroxylase mRNA express... |
Brain Res Mol Brain ... |
2004 |
Albers C, Kohler H, Lehr ... |
Development of a psilocin immunoassay for serum and blood samples |
Int J Legal Med |
2004 |
Sotnikova TD, Beaulieu JM... |
Dopamine-Independent Locomotor Actions of Amphetamines in a Novel Acut... |
PLoS Biol |
2005 |
Burchett SA, Hicks TP |
The mysterious trace amines: protean neuromodulators of synaptic trans... |
Prog Neurobiol |
2006 |
Freudenmann RW, Oxler F, ... |
The origin of MDMA (ecstasy) revisited: the true story reconstructed f... |
Addiction |
2006 |
Capela JP, Macedo C, Bran... |
Neurotoxicity mechanisms of thioether ecstasy metabolites |
Neuroscience |
2007 |
Weyermann C, Marquis R, D... |
Drug intelligence based on MDMA tablets data / I. Organic impurities p... |
Forensic Sci Int |
2007 |
Ambrose JB, Bennett HD, L... |
Cerebral vasculopathy after 4-bromo-2,5-dimethoxyphenethylamine ingest... |
Neurologist |
2010 |
Dal Cason TA, Corbett CA,... |
An unusual clandestine laboratory synthesis of 3,4-methylenedioxyamphe... |
Forensic Sci Int |
2012 |
Katselou M, Papoutsis I, ... |
Fenethylline (Captagon) Abuse. Local Problems from an Old Drug become ... |
Basic Clin Pharmacol... |
2016 |
Heather E, Shimmon R, McD... |
Organic Impurity Profiling of 3,4-Methylenedioxymethamphetamine ... |
Forensic Sci Int |
2020 |